Critical illness survivors demonstrate accelerated epigenetic aging in skeletal muscle five years post-ICU discharge, yet this epigenetic acceleration does not explain their persistent muscle weakness. The finding suggests that post-ICU muscle impairment operates through mechanisms beyond standard epigenetic clock measurements, requiring alternative biological markers to predict long-term functional decline.
Key Points
- ICU survivors show accelerated muscle epigenetic aging five years later
- Epigenetic acceleration does not correlate with reduced muscle strength
- Current epigenetic clocks miss critical mechanisms driving muscle weakness
Longevity Analysis
This research exposes a gap between measurable biological aging and functional outcomes in a population at high risk for accelerated decline. ICU survivors face persistent muscle weakness despite apparent recovery, yet standard epigenetic markers fail to capture the underlying pathology. This disconnect points to the necessity of understanding how critical illness disrupts muscle regeneration and protein synthesis through pathways that remain invisible to current aging biomarkers. Practitioners assessing long-term recovery in this population cannot rely on epigenetic age acceleration as a predictor of muscle function; instead, direct assessment of strength, fiber composition, and transcriptional disruption becomes essential for designing targeted rehabilitation and nutritional interventions.
Original published by Wiley Aging Cell, by Ceren Uzun Ayar, Inge Derese, Greet Van den Berghe, Ilse Vanhorebeek .